Skip to main content
. 2023 Nov 29;9(12):e22957. doi: 10.1016/j.heliyon.2023.e22957

Table 2.

Cardio-cerebrovascular functional modulation of phthalides.

Cardio-cerebr-ovascular functions Phthalides Possible mechanisms Reference
Angiogenesis or neovascularization Ligustilide Increase cerebral vessels number, VEGF and eNOS activation [17]
Butylphthalide Alter Ang-1/Ang-2/Tie-2 signaling axis [88]
Butylphthalide Promote VEFG and Ang-1, and upregulate sonic hedgehog expression [89]
Butylidenephthalide Enhance VEGF and BDNF expressions via activation of AKT/mTOR signal pathway [90]
Protection on endothelial cells Ligustilide Stimulate NRF2/ARE pathway [91]
Butylphthalide Maintain the endothelial PGC-1α expression via regulating eNOS activity [92]
Butylidenephthalide Elevate the pool of PI species, and inhibit the phosphorylation of PLCλ and ERK1/2 [93]
Levistilide A Suppress NLRP3 gene expression by blocking the Syk–p38/JNK pathway [94]
Z,Z′-3a.7a′,7a.3a′-dihydroxyligustilide Increase the viability and proliferation of HUVECs, and reduce the apoptosis [95]
Smooth muscle relaxation, inhibition of VSMCs abnormal proliferation and migration Ligustilide Downregulate c-Myc/MMP2 signaling pathway and ROCK-JNK signaling pathway [96]
Butylphthalide Inhibit the β-catenin signaling pathway [97]
Butylidenephthalide Phosphorylate JNK and p38 MAPK, and upregulate Nur77 gene [98]
Vasodilatation or vasorelaxation activities Ligustilide Inhibit [Ca2+] influx and cold-sensing protein TRPM8 and TRPA1 [99]
Butylphthalide Increase the regional blood flow by preventing vasoconstriction of the artery and maintaining its diameter at normal level [100]
Senkyunolide A Inhibit RYRs and VDCCs [101]
Anti-arthrosclerosis effects Ligustilide and Senkyunolide A Inhibit CD137 expression through suppressing AP-1 and AKT/NF-κB signaling pathway [102]
Ligustilide Activate Nrf2/HO-1 induction and NO synthesis [103]
Ligustilide Activate Nrf2 and ARE-driven genes [91]
Anti-thrombotic effects Butylphthalide Inhibit human platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and PDE [104]
(S)-ZJM-289, a nitric oxide-releasing derivative of 3-n-butylphthalide Maintain mitochondrial integrity and function, and block mitochondria-mediated cell death possibly by upregulation of Hsp70 [105]
3-Butyl-2-benzothiophen-1(3H)-one (5d) Decrease NADPH oxidase activity by promoting Nrf2 nuclear localization through PI3K/Akt signaling pathway [106]
Anti-myocardial ischemia effects Ligustilide and Cnidilide Reduce serum lactic acid and free fatty acid [107]
Butylphthalide Inhibit inflammatory and oxidative stress responses by regulating the Akt/Nrf2 signaling pathway [108]
Butylidenephthalide Target the PI3K/STAT3 axis [12]